These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 20200060

  • 1. Bad medicine: type 2 diabetes.
    Spence D.
    BMJ; 2010 Mar 03; 340():c1216. PubMed ID: 20200060
    [No Abstract] [Full Text] [Related]

  • 2. Five Ms of adherence.
    Bloomgarden Z, Dagogo-Jack S.
    J Diabetes; 2011 Sep 03; 3(3):169-71. PubMed ID: 21631902
    [No Abstract] [Full Text] [Related]

  • 3. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice.
    van Bruggen R, Gorter K, Stolk RP, Zuithoff P, Klungel OH, Rutten GE.
    Pharmacoepidemiol Drug Saf; 2009 Nov 03; 18(11):983-91. PubMed ID: 19623570
    [Abstract] [Full Text] [Related]

  • 4. [Drug therapy of hyperglycemia and the prognosis of adult-onset diabetes mellitus].
    Niskanen L, Uusitupa M, Laakso M.
    Duodecim; 1999 Nov 03; 115(10):1122-4. PubMed ID: 11877851
    [No Abstract] [Full Text] [Related]

  • 5. [Type 2 diabetic patients with hypertension: do they prefer treating diabetes or hypertension?].
    El Aassri H, El Mghari G, El Ansari N.
    Pan Afr Med J; 2014 Nov 03; 17():193. PubMed ID: 25396019
    [Abstract] [Full Text] [Related]

  • 6. Early pharmacological intervention in newly diagnosed metabolic syndrome and type 2 diabetes.
    Naruszewicz M.
    Przegl Lek; 2006 Nov 03; 63 Suppl 4():7-8. PubMed ID: 16967707
    [No Abstract] [Full Text] [Related]

  • 7. Clinical trials and clinical practice--bridging the gaps in type 2 diabetes. An evidence-based approach to risk factor modification in type 2 diabetes.
    Greenfield JR, Chisholm DJ.
    Aust N Z J Med; 2000 Aug 03; 30(4):483-91. PubMed ID: 10985515
    [No Abstract] [Full Text] [Related]

  • 8. [What should be the target of therapy in the adult-onset diabetes mellitus?].
    Yki-Järvinen H.
    Duodecim; 1999 Aug 03; 115(10):1119-20. PubMed ID: 11877850
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Drug prevention of coronary disease].
    Miettinen TA.
    Duodecim; 1972 Aug 03; 88(21):1346-54. PubMed ID: 4570871
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Intensified treatment of type 2 diabetes mellitus. Is polypharmacy necessary and justified?].
    Pedersen OB, Gaede PH.
    Ugeskr Laeger; 2000 Jun 19; 162(25):3582-91. PubMed ID: 11016281
    [Abstract] [Full Text] [Related]

  • 17. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.
    Sirois C, Moisan J, Poirier P, Grégoire JP.
    Diabetes Care; 2007 Jul 19; 30(7):1880-2. PubMed ID: 17384345
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of type 2 diabetes mellitus by changes in lifestyle.
    Fodor JG, Adamo KB.
    N Engl J Med; 2001 Aug 30; 345(9):696; author reply 696-7. PubMed ID: 11547727
    [No Abstract] [Full Text] [Related]

  • 20. Combination of drugs in the management of diabetes mellitus.
    Das S.
    J Indian Med Assoc; 2002 Jul 30; 100(7):434, 436, 445-7. PubMed ID: 12674168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.